Мы в Telegram
Добавить новость
smi24.net
Forbes.com
Октябрь
2021

Новости за 04.10.2021

Mazda MX-30 - Sometimes It's OK To Comply

Forbes.com 

Despite Mazda's protests to the contrary, the 2022 MX-30, the brand's first EV is a compliance car, but that's not necessarily a bad thing



With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision

Forbes.com 

Merck yesterday announced that it will acquire Acceleron Pharma - a biopharmaceutical company focused on rare diseases - for $11.5 billion funded in cash and debt. Acceleron has multiple potentially blockbuster drugs in its pipeline. To name a few, Sotatercept - is in late stage clinical trials...





СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *